REGN
Regeneron Pharmaceuticals, Inc.
Stock
$735.20+0.39 (+0.05%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $2.7B
- YoY, 2025
- −8.6%
- 5-year CAGR
- +14.9%
- 10-year CAGR
- +12.4%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $2.7B | −8.6% |
| 2024 | $3.0B | +12.3% |
| 2023 | $2.6B | +24.4% |
| 2022 | $2.1B | +15.9% |
| 2021 | $1.8B | +35.6% |
| 2020 | $1.3B | +0.3% |
| 2019 | $1.3B | +19.0% |
| 2018 | $1.1B | −14.6% |
| 2017 | $1.3B | +12.1% |
| 2016 | $1.2B | +40.4% |
| 2015 | $839M | +61.5% |
| 2014 | $519M | +49.9% |
| 2013 | $346M | +64.4% |
| 2012 | $211M | +79.7% |
| 2011 | $117M | +79.8% |
| 2010 | $65M | +23.2% |
| 2009 | $53M | +8.3% |
| 2008 | $49M | — |